Tuan Zea Tan Selected Research

Tuan Zea Tan Research Topics

Disease

38	Neoplasms (Cancer) 10/2022 - 05/2014
12	Breast Neoplasms (Breast Cancer) 09/2021 - 05/2014
10	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 07/2013
7	Carcinoma (Carcinomatosis) 12/2020 - 01/2015
6	Neoplasm Metastasis (Metastasis) 04/2021 - 09/2014
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 12/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 05/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
3	Triple Negative Breast Neoplasms 09/2021 - 08/2014
3	Ovarian Epithelial Carcinoma 01/2021 - 11/2017
3	Colonic Neoplasms (Colon Cancer) 11/2016 - 01/2016
2	Fanconi Anemia (Fanconi's Anemia) 01/2022 - 01/2018
2	Genomic Instability 01/2022 - 01/2018
2	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2019
2	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Disease Progression 09/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Pathologic Processes 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Pulmonary Tuberculosis 01/2021
1	Iron Overload 12/2020
1	Necrosis 12/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Adenoma (Adenomas) 01/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2015
9	Biomarkers (Surrogate Marker)IBA 10/2022 - 09/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
4	CytokinesIBA 01/2022 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2014
3	ChromatinIBA 01/2021 - 01/2018
3	Biological ProductsIBA 01/2021 - 12/2014
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 12/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2017
2	Histone Deacetylase InhibitorsIBA 09/2021 - 01/2019
2	PPAR gammaIBA 09/2021 - 05/2014
2	VimentinIBA 03/2021 - 01/2015
2	PlatinumIBA 01/2021 - 12/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2016
2	Metalloproteases (Metalloproteinases)IBA 01/2021 - 09/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 11/2020
2	CateninsIBA 01/2020 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2019
2	Phenobarbital (Luminal)FDA Link 01/2019 - 09/2014
2	LigandsIBA 01/2017 - 05/2014
2	Messenger RNA (mRNA)IBA 04/2016 - 01/2016
2	Superoxide DismutaseIBA 01/2016 - 05/2014
2	Small Interfering RNA (siRNA)IBA 09/2015 - 07/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2022
1	TNF Receptor-Associated Factor 4IBA 10/2022
1	CarcinogensIBA 10/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	OsteopontinIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	PanobinostatIBA 09/2021
1	Rosiglitazone (Avandia)FDA Link 09/2021
1	SolutionsIBA 04/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 02/2021
1	Therapeutic UsesIBA 02/2021
1	asoxime chloride (H16)IBA 01/2021
1	AntigensIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Rad51 RecombinaseIBA 01/2021
1	SulfurIBA 12/2020
1	Cysteine (L-Cysteine)FDA Link 12/2020
1	IronIBA 12/2020
1	Cytotoxins (Cytolysins)IBA 12/2020
1	sotorasibIBA 11/2020
1	ChemokinesIBA 10/2020
1	Cytoskeletal ProteinsIBA 01/2020
1	cannogenin thevetoside (peruvoside)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	Axl Receptor Tyrosine KinaseIBA 01/2020
1	Eph Family Receptors (Eph Receptors)IBA 01/2020
1	Codon (Codons)IBA 01/2020
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 01/2020
1	trametinibIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 12/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019

Therapy/Procedure

18	Therapeutics 01/2022 - 05/2014
5	Drug Therapy (Chemotherapy) 01/2021 - 09/2014
2	Immunotherapy 04/2020 - 01/2017
1	Radiotherapy 01/2021
1	Transplantation 11/2020